We at ACSH have long admired the efforts of Dr. Channapatna Prakash to demystify the science and facts around bioengineering and GMO agriculture. Now we are delighted to learn that Dr. Prakash has received the 2015 Borlaug CAST (Council for Agricultural Science and Technology) Communicator Award.
Genetic engineering
Although anti-GMO activists will undoubtedly disagree, we here at ACSH compliment the FDA for its approval of genetically engineered (GMO) apples and potatoes.
According to an article in the New York Times, while a majority of consumers surveyed think it s important to know if foods are made with genetically engineered (GMO) ingredients, most are pretty ignorant about what s already out there in the marketplace.
As one of only a few states that have passed laws requiring the labeling of genetically engineered (GMO) foods or ingredients, Vermont is feeling its way carefully.
Dengue and chikungunya are both viruses spread by a species of mosquito known as Aedes aegypti. Dengue sickens 50 million people worldwide and chikungunya infected
Dr. Alan Moghissi of the Potomac Institute for Policy Studies (and former chairman of the ACSH Board of Directors) and colleagues cogently reviewed the evolution of
A cogent commentary in the Teton Valley News notes that advocates of labeling laws are trying to solve a problem that does not exist.
Some European countries are among the most strongly opposed to genetic-engineering in the world. But those that are part of the European Union have not been able to outlaw all planting of GE crops as they wished because these moves have been challenged.
If it were not so deadly serious, it would be rather amusing to see arguments over the latest approval of a genetically engineered crop potatoes by the USDA.
According to an account in the Hindustan Times, the Indian government has decided to allow field testing of two GM crops, mustard and brinjal (eggplant).
According to a recent report, since 1996 there have been over 5 billion acres of biotech crops harvested.
In an opinion piece published in today s Wall Street Journal, Dr. Henry I. Miller, Robert Wesson Fellow in Scientific Philosophy and Public Policy at Stanford s Hoover Institution and former ACSH trustee, discusses the significant benefit that biopharming can provide for the development of medicines if only regulators can become more tolerant.